7-148367794-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.3476-15855A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.717 in 151,960 control chromosomes in the GnomAD database, including 40,186 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.72 ( 40186 hom., cov: 31)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.65

Publications

4 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.794 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014141.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
NM_014141.6
MANE Select
c.3476-15855A>G
intron
N/ANP_054860.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
ENST00000361727.8
TSL:1 MANE Select
c.3476-15855A>G
intron
N/AENSP00000354778.3
CNTNAP2
ENST00000463592.3
TSL:1
c.-194-15855A>G
intron
N/AENSP00000486292.1
CNTNAP2
ENST00000628930.2
TSL:2
c.653-15855A>G
intron
N/AENSP00000487516.1

Frequencies

GnomAD3 genomes
AF:
0.717
AC:
108922
AN:
151842
Hom.:
40167
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.538
Gnomad AMI
AF:
0.912
Gnomad AMR
AF:
0.806
Gnomad ASJ
AF:
0.804
Gnomad EAS
AF:
0.723
Gnomad SAS
AF:
0.646
Gnomad FIN
AF:
0.757
Gnomad MID
AF:
0.790
Gnomad NFE
AF:
0.796
Gnomad OTH
AF:
0.752
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.717
AC:
108974
AN:
151960
Hom.:
40186
Cov.:
31
AF XY:
0.717
AC XY:
53274
AN XY:
74262
show subpopulations
African (AFR)
AF:
0.537
AC:
22250
AN:
41404
American (AMR)
AF:
0.806
AC:
12306
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.804
AC:
2790
AN:
3470
East Asian (EAS)
AF:
0.724
AC:
3747
AN:
5176
South Asian (SAS)
AF:
0.647
AC:
3103
AN:
4794
European-Finnish (FIN)
AF:
0.757
AC:
8003
AN:
10566
Middle Eastern (MID)
AF:
0.784
AC:
229
AN:
292
European-Non Finnish (NFE)
AF:
0.796
AC:
54133
AN:
67970
Other (OTH)
AF:
0.749
AC:
1581
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1432
2863
4295
5726
7158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
830
1660
2490
3320
4150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.771
Hom.:
10537
Bravo
AF:
0.718
Asia WGS
AF:
0.656
AC:
2283
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
0.055
DANN
Benign
0.71
PhyloP100
-2.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1637864; hg19: chr7-148064886; COSMIC: COSV62208195; API